ClinicalThought
View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Gregory Dore, MBBS, PhD, FRACP, MPH, and Stacey Trooskin, MD, PhD, MPH, share lessons learned in the care of patients with HCV infection during the COVID-19 pandemic, including:
Professor, Head
Viral Hepatitis Clinical Research Program
Kirby Institute
University of New South Wales
Professor
Infectious Diseases Physician
St Vincent's Hospital
Sydney, Australia
Chief Medical Officer
Philadelphia FIGHT Community Health Centers
Faculty
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
This program has been made available online.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Dr Nancy Reau on exciting viral hepatitis data from EASL 2022, including HBV, HDV (hepatitis delta), and HCV, from Clinical Care Options (CCO)
Nancy Reau, MD
Released: July 13, 2022
Clinical Care Options (CCO) expert analysis by Prof Tarik Asselah on new viral hepatitis data from EASL 2022, including HBV, HDV, and HCV
Tarik Asselah, MD, PhD
Released: July 8, 2022
Expert selections of important viral hepatitis data from EASL 2022, including studies of patients with HBV, HDV (hepatitis delta virus), and HCV, from Clinical Care Options (CCO)
Tarik Asselah, MD, PhD
Stefan Zeuzem, MD
Released: July 6, 2022
Clinical Care Options (CCO) audio: patient insights on overcoming barriers to HCV care for people with a history of injection drug use
Oluwaseun Falade-Nwulia, MBBS, MPH
Released: April 20, 2022
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.